Nothing Special   »   [go: up one dir, main page]

Brant et al., 2014 - Google Patents

Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection

Brant et al., 2014

View PDF @Full View
Document ID
11013060614663075081
Author
Brant F
Miranda A
Esper L
Rodrigues D
Kangussu L
Bonaventura D
Soriani F
Pinho V
Souza D
Rachid M
Weiss L
Tanowitz H
Teixeira M
Teixeira A
Machado F
Publication year
Publication venue
Infection and immunity

External Links

Snippet

Infection with Plasmodium falciparum may result in severe disease affecting various organs, including liver, spleen, and brain, resulting in high morbidity and mortality. Plasmodium berghei Anka infection of mice recapitulates many features of severe human malaria. The …
Continue reading at journals.asm.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses

Similar Documents

Publication Publication Date Title
Brant et al. Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection
Yang et al. Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair
Knackstedt et al. Neutrophil extracellular traps drive inflammatory pathogenesis in malaria
Rocha et al. Type I interferon transcriptional signature in neutrophils and low-density granulocytes are associated with tissue damage in malaria
Mackroth et al. Acute malaria induces PD1+ CTLA4+ effector T cells with cell-extrinsic suppressor function
Shimokawa et al. Mast cells are crucial for induction of group 2 innate lymphoid cells and clearance of helminth infections
Junqueira et al. Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax–infected reticulocytes
Lizcano et al. Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation
Villegas-Mendez et al. IFN-γ–producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain
Lamikanra et al. Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors
Baptista et al. Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice
Weidner et al. Rapid cytoskeleton remodelling in dendritic cells following invasion by T oxoplasma gondii coincides with the onset of a hypermigratory phenotype
Götz et al. Atypical activation of dendritic cells by Plasmodium falciparum
Hardison et al. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi
Xu et al. Protein quality control through endoplasmic reticulum-associated degradation maintains haematopoietic stem cell identity and niche interactions
Chen et al. A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease
Imai et al. CD8+ T cell activation by murine erythroblasts infected with malaria parasites
Loughland et al. Plasmacytoid dendritic cells appear inactive during sub-microscopic Plasmodium falciparum blood-stage infection, yet retain their ability to respond to TLR stimulation
Hu et al. Absence of tumor necrosis factor supports alternative activation of macrophages in the liver after infection with Leishmania major
Li et al. The role of Tim-3 on dNK cells dysfunction during abnormal pregnancy with Toxoplasma gondii infection
Gun et al. Interferon regulatory factor 1 is essential for pathogenic CD8+ T cell migration and retention in the brain during experimental cerebral malaria
Bakocevic et al. CD 41 is a reliable identification and activation marker for murine basophils in the steady state and during helminth and malarial infections
Hou et al. Down-regulation of Tim-3 in monocytes and macrophages in Plasmodium infection and its association with parasite clearance
Dondji et al. Role for nitric oxide in hookworm-associated immune suppression
Tang et al. All‐trans‐retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune‐mediated aplastic anaemia